Results of a multicentre study show that a sequential high-dose chemotherapy variant of the standard treatment is safe and effective in relapsed Hodgkin’s patients.
Related Articles
Impact Factor
Determining the survival benefit of adjuvant radiotherapy in patients with node-positive head and neck cancer
Grandround
Neurological side-effects caused by recently approved chemotherapy drugs
Impact Factor
Leave a Reply